TScan Therapeutics (TCRX) Competitor Comparison
We are evaluating the key criteria listed to compare TScan Therapeutics (TCRX) against its competitors in the Biotechnology industry.
Market Capitalization
199 / 368Gross Profits
193 / 278Total Revenue
166 / 300EBITDA
186 / 337Free Cashflow
185 / 352Quick Ratio
145 / 357Earnings per Share
97 / 359Dividend yield
0 / 6Total Cash
149 / 358Performance 3 years
174 / 368Performance 5 years
202 / 368Performance 10 years
174 / 368Linearity 3 years
130 / 368Linearity 5 years
161 / 368Linearity 10 years
142 / 368Total Rank
44 / 368Dividend Rank
291 / 368Valuation Rank
2 / 368Piotroski Rank
203 / 368Muliplier Rank
221 / 368Total Cash - TCRX ranking 149 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.